Related Experiment Video

Updated: Aug 9, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

Unbalanced alternative splicing and its significance in cancer

Julian P Venables1

  • 1University of Newcastle-upon-Tyne, Institute of Human Genetics, International Centre for Life, Central Parkway, Newcastle-upon-Tyne, UK. j.venables@ncl.ac.uk

Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|March 21, 2006
PubMed

Insights

Alternative pre-mRNA splicing generates diverse gene products, with altered forms linked to cancer progression and poor prognosis. Understanding these splice variants and their regulatory factors offers new diagnostic and therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Alternative pre-mRNA splicing produces distinct gene expression products crucial for development and disease.
  • Dysregulation of splice variants in genes controlling cell differentiation, apoptosis, invasion, and metastasis is observed in tumors.
  • Aberrant splicing contributes to oncogenesis and can serve as a prognostic marker.

Purpose of the Study:

  • To investigate the role of alternative splicing in cancer development and progression.
  • To highlight the significance of splice variants as potential diagnostic and therapeutic targets.
  • To explore the interplay between alternatively spliced isoforms and splicing factors in pathogenic mechanisms.

Main Methods:

  • Analysis of gene expression data focusing on alternative splicing.
  • Correlation of splice variant overexpression with clinical outcomes.
  • Review of emerging technologies for deciphering splicing factor interactions.

Main Results:

  • Overexpressed splice variants in cancer often encode hyper-oncogenic proteins.
  • These oncogenic splice variants correlate with poor patient prognosis.
  • Perturbation of the delicate equilibrium of splice variants is a hallmark of cancer.

Conclusions:

  • Alternative splicing plays a critical role in cancer pathogenesis.
  • Identifying specific splice variants and their regulatory mutations can improve cancer diagnosis and treatment.
  • Further research into splicing factors and their interplay with isoforms is essential for understanding and targeting cancer.

More Related Videos

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition11:48

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Published on: October 9, 2014

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts11:19

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Published on: October 9, 2016

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...